(MENAFN- Ameliorate Digital Consultancy) The nebulizer devices market refers to the global market for medical devices that are used to administer medication in the form of a mist or aerosol to the respiratory tract of patients. Nebulizers are commonly used to treat respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and other respiratory conditions.
Nebulizer devices come in various forms, including jet nebulizers, ultrasonic nebulizers, and mesh nebulizers. Jet nebulizers are the most commonly used nebulizers and work by compressing air or oxygen through a small opening to generate a fine mist of medication. Ultrasonic nebulizers use high-frequency vibrations to generate a fine mist of medication, while mesh nebulizers use a mesh membrane to produce a fine mist.
Request For Free Sample Report of“Nebulizer Devices Market”@
Firstly, there is an increasing focus on developing new materials which have enhanced biocompatibility capabilities – helping reduce irritation within patients & allowing for comfortable long-term usage. On top of this, many companies are now producing tailored versions that provide specialized solutions for different applications such as home health or clinical settings – meaning users can benefit from optimized forms tailored according to application-specific needs. Furthermore, numerous organizations have begun offering value added services such as imaging analysis packages or remote control access – helping them remain compliant whilst ensuring data safety is maintained across all facilities.
In addition, there is an increasingly growing demand for single-use systems due to their convenience & cost-effectiveness; providing healthcare workers with a safe solution without needing to worry about sterilization or cross contamination between patients. Furthermore, digital solutions have become commonplace amongst nebulizer devices; users can now efficiently store & transfer data from anywhere in the world – greatly reducing administrative burden & improving communication between providers & patients alike.
Companies
Agilent Technologies, Inc. Allied Healthcare Products, Inc. CareFusion Corporation (sub. Becton, Dickinson and Company) Covidien plc (sub. Medtronic) GE Healthcare GF Health Products Inc. Omron Healthcare, Inc. PARI GmbH Koninklijke Philips N.V.
Buy Full Report Now @
Asia Pacific to give tough competition to developed regions
The growing prevalence of chronic obstructive pulmonary disease or COPD in Asia Pacific has intensified the use of nebulizer devices in the region. Chronic obstructive pulmonary disease is a term used to describe a chronic progressive condition of lung disorders such as asthma and chronic bronchitis. As per the Journal of Thoracic Disease, the prevalence rate of COPD cases in China is 8.2% and is related to the increase in exposure to biomass smoke.
According to the Journal of Lung, Pulmonary & Respiratory Research, it is estimated that there are 5 lakh deaths in India every year due to COPD. According to the World Health Organization, COPD prevalence in New Zealand is between 10% and 17% of the total population.
According to the Lung Foundation Australia, 7.5% of Australians above 40 years of age suffer from COPD. Moreover, the growing disposable income of consumers in the region allows them to afford more advanced technologies and adopt better treatment options. As a result, the demand for nebulizer devices in the APEJ region is expected to intensify over the coming years.
Request Customization @
Nebulizer Devices Market: Segmentation
| By Product Type | Compressed Jet Nebulizer Breath Actuated Pneumatic Nebulizer Vented Actuated Pneumatic Nebulizer Ultrasound Nebulizer Mesh Nebulizer |
| By End User | Homecare Settings Out Patient Settings Others Hospitals Clinics Long Term Centers |
| By Application | COPD Cystic Fibrosis Asthma Others |
Check out more Premium studies published by Persistence Market Research
cell counting market
dna and rna sample preparation market
single-use bioprocess systems market
macular degeneration treatment market
lensometer market
About Us
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.
Contact Us:
Persistence Market Research
United States
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales –